- Dialysis and Renal Disease Management
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
- Pregnancy and Medication Impact
- Pregnancy and preeclampsia studies
- Diet and metabolism studies
- Parathyroid Disorders and Treatments
- Birth, Development, and Health
- Climate Change and Health Impacts
- Systemic Lupus Erythematosus Research
- Nutritional Studies and Diet
- Diabetes Treatment and Management
- Electrolyte and hormonal disorders
- Nutrition and Health in Aging
- Biomedical Research and Pathophysiology
- Health Systems, Economic Evaluations, Quality of Life
- Neurological and metabolic disorders
- Myasthenia Gravis and Thymoma
- Maternal and fetal healthcare
- Magnesium in Health and Disease
- Vasculitis and related conditions
- Muscle and Compartmental Disorders
- Liver Disease Diagnosis and Treatment
- Reproductive System and Pregnancy
- Renal and Vascular Pathologies
University of Messina
2020-2025
Centre Hospitalier du Mans
2020-2024
Azienda Ospedaliera Universitaria Policlinico "G. Martino"
2020-2024
Azienda Ospedaliero-Universitaria di Modena
2008
Incremental hemodialysis (iHD) may attenuate "dialysis shock" and reduce costs, preserving quality of life. It is considered difficult to reconcile with HD wards' routine; fear underdialysis increasing mortality are additional concerns. The aim this study was evaluate mortality, morbidity, costs in a large ward where iHD the standard start. This observational included all incident patients 2017 2021, stratified according start: (1-2 sessions/wk), decremental (dHD, 3 sessions/wk at start,...
Little is known about the effect tubulointerstitial nephropathies have in modulating maternal-fetal outcomes pregnancy. Therefore, we analyzed main of pregnancy these women to gain a better understanding role reduction maternal kidney mass. From Torino Cagliari Observational Study (TOCOS) cohort, selected 529 patients with diagnosis disease and focused on 421 chronic (CKD) stage 1, without hypertension but proteinuria less than 0.5 g/day at referral. cohort 2969 singleton deliveries from...
Hypercalcemia is defined as a serum calcium concentration higher than 10.5 mg/gL or 2.6 mmol/L. Only 50% of active, presented ionized calcium. The remaining half bound to albumin, phosphate, and other anions, their changes can affect the concentration. Thus, discriminate true hypercalcemia from pseudo hypercalcemia, an 1.3 mmol/L might be more appropriate. Many variables lead managing them necessary treat this ion disorder. Indeed, it caused by malignancies, hematologic disorders, genetic...
Introduction. Treating hyperkalemia is one of the main goals supportive care in patients on hemodialysis. In this context, therapy with new potassium binders a promising resource. Objective. The aim to evaluate difference serum concentration after treatment sodium zirconium cyclosilicate or patiromer compared placebo/sodium polystyrene sulfonate/calcium sulfonate. Methods. We will perform systematic research PubMed, EMBASE, CINAHLE, and grey literature be screened. screen RCTs treated SZC...
Abstract: Hyperphosphataemia represents a significant challenge in the management of chronic kidney disease, exerting pronounced influence on pathogenesis cardiovascular complications and mineral bone disorders. Traditional approaches to address hyperphosphataemia involve implementing dietary phosphate restrictions, administering binders, and, cases end-stage renal resorting dialysis. Unfortunately, these interventions frequently prove inadequate maintaining levels within recommended ranges....
Chronic kidney disease (CKD) is widespread throughout the world, with a high social and health impact. It considered 'silent killer' for its sudden onset without symptoms in early stages of disease. The main goal nephrologists to slow progression treat associated range new medications.
Prescribing a low-protein diet (LPD) is part of the standard management patients in advanced stages chronic kidney disease (CKD). However, studies on quality life (QoL) LPDs are lacking, and impact these diets have their QoL often given as reason for not prescribing one. We, therefore, decided to assess cohort CKD stage 3–5 followed up by multiple-choice approach an outpatient nephrology clinic France. To do so, we used short version World Health Organization’s questionnaire compared results...
(1) Background: This observational study aimed to verify the association between serum potassium levels and hospitalization days in patients with chronic kidney disease a follow up of nine months. (2) Methods: Patients were divided into group A (180 patients, ≤ 5.1 mEq/L) B (90 > mEq/L). Student's t-test, Mann-Whitney test, Pearson's Chi-Square Pearson/Spearman's correlation test linear regression performed entire sample stage-G4/5 subsample. (3) Results: Groups differed for estimated...
Background: Pregnancy involves complex hemodynamic and immune adaptations to support the developing fetus. The kidney assumes a pivotal role in orchestrating these mechanisms. However, renal disease poses potential risk for adverse maternal–fetal outcomes. While function, hypertension, proteinuria are recognized as key influencers of risk, mere presence glomerular disease, independent factors, may wield significant impact. Methods: A brief review existing literature was conducted synthesize...
ABSTRACT Pregnancy in women living with chronic kidney disease (CKD) was often discouraged due to the risk of adverse maternal–fetal outcomes and progression disease. This negative attitude has changed recent years, greater emphasis on patient empowerment than imperative ‘non nocere’. Although risks persist, pregnancy even advanced CKD have significantly improved, for both mother newborn. Adequate counselling can help minimize support a more conscious informed approach those that are...
Audits allow analysis of the delivery care and prevalence diseases. This study investigated kidney diseases’ impact on end-stage renal disease (ERSD) in patients younger than 30 years. Methods: is retrospectively conducted young dialysis-dependent included Sicilian Registry Nephrology, Dialysis Transplantation Participants. It evaluated who started dialysis before age retrieved mentioned registry. The sample was divided into two groups, according to presence or absence a specific diagnosis....